Menu
Symphony™ is different.
Symphony™ is a highly customizable, proprietary, AI drug discovery platform purpose-built for biological discovery. It utilizes the widest biomedical data landscapes available in combination with a proprietary artificial intelligence platform.
It is the only drug discovery platform to integrate and simultaneously analyze multiple unrelated heterogeneous data types in one process in a fully traceable, rationalized approach.
A pipeline built with confidence.
Symphony™ not only breaks the data silos that challenge traditional drug discovery but gives Aria scientists the insights necessary to mitigate drug development risks and maximize the likelihood of choosing the best candidates for success at Phase 1 and Phase 2 milestones. This allows us to choose candidates to advance that will be more likely to see clinical success.
A pipeline built with confidence.
Symphony™ not only breaks the data silos that challenge traditional drug discovery but gives Aria scientists the insights necessary to mitigate drug development risks and maximize the likelihood of choosing the best candidates for success at Phase 1 and Phase 2 milestones.
This allows us to choose candidates to advance that will be more likely to see clinical success. In fact, our combined likelihood of success in preclinical and Phase 2 milestones is over 50x higher than traditional research and development approaches.
Always improving prediction capabilities.
Symphony™ continuously improves its prediction quality over time with an iterative approach to algorithm and data enhancements through its ability to rapidly intake new biomedical data in any form. Aria has released new versions of the Symphony™ platform more than 340 times to date, making it one of the most sophisticated drug discovery platforms in the industry.
For more information on how we make clinical predictions, click here.
